209 related articles for article (PubMed ID: 27436360)
21. Ligand-stimulated VEGFR2 signaling is regulated by co-ordinated trafficking and proteolysis.
Bruns AF; Herbert SP; Odell AF; Jopling HM; Hooper NM; Zachary IC; Walker JH; Ponnambalam S
Traffic; 2010 Jan; 11(1):161-74. PubMed ID: 19883397
[TBL] [Abstract][Full Text] [Related]
22. Endothelial SCUBE2 Interacts With VEGFR2 and Regulates VEGF-Induced Angiogenesis.
Lin YC; Chao TY; Yeh CT; Roffler SR; Kannagi R; Yang RB
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):144-155. PubMed ID: 27834687
[TBL] [Abstract][Full Text] [Related]
23. BMP6/TAZ-Hippo signaling modulates angiogenesis and endothelial cell response to VEGF.
Pulkkinen HH; Kiema M; Lappalainen JP; Toropainen A; Beter M; Tirronen A; Holappa L; Niskanen H; Kaikkonen MU; Ylä-Herttuala S; Laakkonen JP
Angiogenesis; 2021 Feb; 24(1):129-144. PubMed ID: 33021694
[TBL] [Abstract][Full Text] [Related]
24. Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels.
Ding C; Luo J; Fan X; Li L; Li S; Wen K; Feng J; Wu G
J Exp Clin Cancer Res; 2017 Apr; 36(1):56. PubMed ID: 28420432
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis.
Mahabeleshwar GH; Feng W; Reddy K; Plow EF; Byzova TV
Circ Res; 2007 Sep; 101(6):570-80. PubMed ID: 17641225
[TBL] [Abstract][Full Text] [Related]
26. Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression.
Stepanova V; Jayaraman PS; Zaitsev SV; Lebedeva T; Bdeir K; Kershaw R; Holman KR; Parfyonova YV; Semina EV; Beloglazova IB; Tkachuk VA; Cines DB
J Biol Chem; 2016 Jul; 291(29):15029-45. PubMed ID: 27151212
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation.
Lin MT; Yen ML; Lin CY; Kuo ML
Mol Pharmacol; 2003 Nov; 64(5):1029-36. PubMed ID: 14573751
[TBL] [Abstract][Full Text] [Related]
28. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
[TBL] [Abstract][Full Text] [Related]
29. Targeting VEGF-A/VEGFR2 Y949 Signaling-Mediated Vascular Permeability Alleviates Hypoxic Pulmonary Hypertension.
Zhou W; Liu K; Zeng L; He J; Gao X; Gu X; Chen X; Jing Li J; Wang M; Wu D; Cai Z; Claesson-Welsh L; Ju R; Wang J; Zhang F; Chen Y
Circulation; 2022 Dec; 146(24):1855-1881. PubMed ID: 36384284
[TBL] [Abstract][Full Text] [Related]
30. Protein Phosphotyrosine Phosphatase 1B (PTP1B) in Calpain-dependent Feedback Regulation of Vascular Endothelial Growth Factor Receptor (VEGFR2) in Endothelial Cells: IMPLICATIONS IN VEGF-DEPENDENT ANGIOGENESIS AND DIABETIC WOUND HEALING.
Zhang Y; Li Q; Youn JY; Cai H
J Biol Chem; 2017 Jan; 292(2):407-416. PubMed ID: 27872190
[TBL] [Abstract][Full Text] [Related]
31. Temporal Dynamics of VEGFA-Induced VEGFR2/FAK Co-Localization Depend on SHB.
Pietilä I; Van Mourik D; Tamelander A; Kriz V; Claesson-Welsh L; Tengholm A; Welsh M
Cells; 2019 Dec; 8(12):. PubMed ID: 31847469
[TBL] [Abstract][Full Text] [Related]
32. AIP1 functions as an endogenous inhibitor of VEGFR2-mediated signaling and inflammatory angiogenesis in mice.
Zhang H; He Y; Dai S; Xu Z; Luo Y; Wan T; Luo D; Jones D; Tang S; Chen H; Sessa WC; Min W
J Clin Invest; 2008 Dec; 118(12):3904-16. PubMed ID: 19033661
[TBL] [Abstract][Full Text] [Related]
33. Herbal compound farnesiferol C exerts antiangiogenic and antitumor activity and targets multiple aspects of VEGFR1 (Flt1) or VEGFR2 (Flk1) signaling cascades.
Lee JH; Choi S; Lee Y; Lee HJ; Kim KH; Ahn KS; Bae H; Lee HJ; Lee EO; Ahn KS; Ryu SY; Lü J; Kim SH
Mol Cancer Ther; 2010 Feb; 9(2):389-99. PubMed ID: 20103598
[TBL] [Abstract][Full Text] [Related]
34. Sphingosine-1-Phosphate Receptor 1 Activity Promotes Tumor Growth by Amplifying VEGF-VEGFR2 Angiogenic Signaling.
Balaji Ragunathrao VA; Anwar M; Akhter MZ; Chavez A; Mao Y; Natarajan V; Lakshmikanthan S; Chrzanowska-Wodnicka M; Dudek AZ; Claesson-Welsh L; Kitajewski JK; Wary KK; Malik AB; Mehta D
Cell Rep; 2019 Dec; 29(11):3472-3487.e4. PubMed ID: 31825830
[TBL] [Abstract][Full Text] [Related]
35. Vascular endothelial-cadherin tyrosine phosphorylation in angiogenic and quiescent adult tissues.
Lambeng N; Wallez Y; Rampon C; Cand F; Christé G; Gulino-Debrac D; Vilgrain I; Huber P
Circ Res; 2005 Feb; 96(3):384-91. PubMed ID: 15662029
[TBL] [Abstract][Full Text] [Related]
36. MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathway.
Lorenzon E; Colladel R; Andreuzzi E; Marastoni S; Todaro F; Schiappacassi M; Ligresti G; Colombatti A; Mongiat M
Oncogene; 2012 Jun; 31(26):3136-47. PubMed ID: 22020326
[TBL] [Abstract][Full Text] [Related]
37. eNOS-induced vascular barrier disruption in retinopathy by c-Src activation and tyrosine phosphorylation of VE-cadherin.
Ninchoji T; Love DT; Smith RO; Hedlund M; Vestweber D; Sessa WC; Claesson-Welsh L
Elife; 2021 Apr; 10():. PubMed ID: 33908348
[TBL] [Abstract][Full Text] [Related]
38. Endothelial VEGFR2-PLCγ signaling regulates vascular permeability and antitumor immunity through eNOS/Src.
Sjöberg E; Melssen M; Richards M; Ding Y; Chanoca C; Chen D; Nwadozi E; Pal S; Love DT; Ninchoji T; Shibuya M; Simons M; Dimberg A; Claesson-Welsh L
J Clin Invest; 2023 Oct; 133(20):. PubMed ID: 37651195
[TBL] [Abstract][Full Text] [Related]
39. Activation of Vascular Endothelial Growth Factor (VEGF) Receptor 2 Mediates Endothelial Permeability Caused by Cyclic Stretch.
Tian Y; Gawlak G; O'Donnell JJ; Birukova AA; Birukov KG
J Biol Chem; 2016 May; 291(19):10032-45. PubMed ID: 26884340
[TBL] [Abstract][Full Text] [Related]
40. Transactivation of vascular endothelial growth factor receptor-2 by interleukin-8 (IL-8/CXCL8) is required for IL-8/CXCL8-induced endothelial permeability.
Petreaca ML; Yao M; Liu Y; Defea K; Martins-Green M
Mol Biol Cell; 2007 Dec; 18(12):5014-23. PubMed ID: 17928406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
